Navire Pharma has a total of 40 patents globally, out of which 5 have been granted. Of these 40 patents, all patents are active. United States of America is where Navire Pharma has filed the maximum number of patents, followed by Mexico and Israel. Parallelly, United States of America seems
Cirius Therapeutics has a total of 31 patents globally, out of which 24 have been granted. Of these 31 patents, more than 83% patents are active. New Zealand is where Cirius Therapeutics has filed the maximum number of patents, followed by Hungary and Austria. Parallelly, United States of America seems
Cersci Therapeutics has a total of 43 patents globally, out of which 6 have been granted. Of these 43 patents, more than 67% patents are active. United States of America is where Cersci Therapeutics has filed the maximum number of patents, followed by Mexico and Australia. Parallelly, United States of
Blossomhill Therapeutics has a total of 40 patents globally, out of which 1 has been granted. Of these 40 patents, more than 90% patents are active. Taiwan is where Blossomhill Therapeutics has filed the maximum number of patents, followed by Argentina and Brazil. Parallelly, United States of America seems to
Aivita Biomedical has a total of 58 patents globally, out of which 7 have been granted. Of these 58 patents, more than 79% patents are active. United States of America is where Aivita Biomedical has filed the maximum number of patents, followed by Australia and Japan. Parallelly, United States of
Agenovir has a total of 71 patents globally, out of which 1 has been granted. Of these 71 patents, more than 5% patents are active. United States of America is where Agenovir has filed the maximum number of patents, followed by Europe and Canada. Parallelly, United States of America seems
Scorpion Therapeutics has a total of 42 patents globally, out of which none have been granted. Of these 42 patents, more than 80% patents are active. The United States of America seems to be the main focused R&D centre and also is the origin country of Scorpion Therapeutics. Scorpion Therapeutics
Lyndra Therapeutics has a total of 101 patents globally, out of which 15 have been granted. Of these 101 patents, more than 96% patents are active. Japan is where Lyndra Therapeutics has filed the maximum number of patents, followed by United States of America and Canada. Parallely, United States of
Dragonfly Therapeutics has a total of 683 patents globally, out of which 20 have been granted. Of these 683 patents, more than 87% patents are active. The United States of America and Japan is where Dragonfly Therapeutics has filed the maximum number of patents, followed by Singapore and Europe. Parallely,
Acrotech Biopharma has a total of 32 patents globally, out of which 26 have been granted. Of these 32 patents, more than 87% patents are active. The United States of America is where Acrotech Biopharma has filed the maximum number of patents. Parallelly, United States of America seems to be
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.